{"title":"快速丸治疗后深度低钠血症的纠正:基于Edelman方程的Barsoum-Levine公式的有效性。","authors":"Koya Nagase, Takahiro Imaizumi, Atsushi Yamamori, Yuna Hiramatsu, Minori Kambe, Yungri Kang, Yukari Kishima, Yoshiaki Kozaki, Fumika N Nagase, Keita Iwasaki, Yuuki Ito, Hiroki Ikai, Mari Yamamoto, Yukari Murai, Waka Yokoyama-Kokuryo, Naoho Takizawa, Hideaki Shimizu, Yoshiro Fujita, Tsuyoshi Watanabe","doi":"10.1093/ckj/sfae402","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The optimal treatment for profound hyponatraemia remains uncertain. Recent clinical studies have demonstrated that a standardized bolus of hypertonic saline is effective, but relying solely on this approach may not fully address the individual variability of hyponatraemia among patients. We evaluated the effectiveness of rapid bolus (RB) administration of hypertonic saline followed by predictive correction (PC) using an infusate and fluid loss formula identical to the Barsoum-Levine formula based on the Edelman equation (RB-PC) for managing profound hyponatraemia.</p><p><strong>Methods: </strong>In this retrospective observational cohort study, we evaluated 276 patients aged >18 years with s[Na] levels ≤120 mEq/L (January 2014-December 2023). Using propensity score matching (PSM), we assessed s[Na] elevations at 6 h post-treatment initiation and the rate of appropriate hyponatraemia correction between the RB-PC and PC groups. We defined the appropriate correction as a change in s[Na] in the range of 4-10 mEq/L within the first 24 h and ≤18 mEq/L within the first 48 h following corrective treatment initiation.</p><p><strong>Results: </strong>Among 276 patients with profound hyponatraemia (s[Na] ≤120 mEq/L), 49 and 108 underwent treatment with RB-PC therapy and with PC therapy without RB, respectively. Post-PSM, 84 patients were selected and allocated to the RB-PC (<i>n</i> = 42) or PC group (<i>n</i> = 42). In PSM analysis, patients with RB-PC experienced a higher elevation in s[Na] at 6 h after treatment initiation than PC (4.0 vs 2.4 mEq/L, <i>P</i> < 0.001). The rate of appropriate correction was similar between the RB-PC and PC groups (90.5% vs 90.5%, <i>P</i> = 1).</p><p><strong>Conclusions: </strong>RB-PC can quickly elevate s[Na] levels and achieve appropriate correction of s[Na] in patients with profound hyponatraemia.</p>","PeriodicalId":10435,"journal":{"name":"Clinical Kidney Journal","volume":"18 2","pages":"sfae402"},"PeriodicalIF":4.6000,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11788568/pdf/","citationCount":"0","resultStr":"{\"title\":\"Correction of profound hyponatraemia following rapid bolus therapy: effectiveness of the Barsoum-Levine formula based on the Edelman equation.\",\"authors\":\"Koya Nagase, Takahiro Imaizumi, Atsushi Yamamori, Yuna Hiramatsu, Minori Kambe, Yungri Kang, Yukari Kishima, Yoshiaki Kozaki, Fumika N Nagase, Keita Iwasaki, Yuuki Ito, Hiroki Ikai, Mari Yamamoto, Yukari Murai, Waka Yokoyama-Kokuryo, Naoho Takizawa, Hideaki Shimizu, Yoshiro Fujita, Tsuyoshi Watanabe\",\"doi\":\"10.1093/ckj/sfae402\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The optimal treatment for profound hyponatraemia remains uncertain. Recent clinical studies have demonstrated that a standardized bolus of hypertonic saline is effective, but relying solely on this approach may not fully address the individual variability of hyponatraemia among patients. We evaluated the effectiveness of rapid bolus (RB) administration of hypertonic saline followed by predictive correction (PC) using an infusate and fluid loss formula identical to the Barsoum-Levine formula based on the Edelman equation (RB-PC) for managing profound hyponatraemia.</p><p><strong>Methods: </strong>In this retrospective observational cohort study, we evaluated 276 patients aged >18 years with s[Na] levels ≤120 mEq/L (January 2014-December 2023). Using propensity score matching (PSM), we assessed s[Na] elevations at 6 h post-treatment initiation and the rate of appropriate hyponatraemia correction between the RB-PC and PC groups. We defined the appropriate correction as a change in s[Na] in the range of 4-10 mEq/L within the first 24 h and ≤18 mEq/L within the first 48 h following corrective treatment initiation.</p><p><strong>Results: </strong>Among 276 patients with profound hyponatraemia (s[Na] ≤120 mEq/L), 49 and 108 underwent treatment with RB-PC therapy and with PC therapy without RB, respectively. Post-PSM, 84 patients were selected and allocated to the RB-PC (<i>n</i> = 42) or PC group (<i>n</i> = 42). In PSM analysis, patients with RB-PC experienced a higher elevation in s[Na] at 6 h after treatment initiation than PC (4.0 vs 2.4 mEq/L, <i>P</i> < 0.001). The rate of appropriate correction was similar between the RB-PC and PC groups (90.5% vs 90.5%, <i>P</i> = 1).</p><p><strong>Conclusions: </strong>RB-PC can quickly elevate s[Na] levels and achieve appropriate correction of s[Na] in patients with profound hyponatraemia.</p>\",\"PeriodicalId\":10435,\"journal\":{\"name\":\"Clinical Kidney Journal\",\"volume\":\"18 2\",\"pages\":\"sfae402\"},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-12-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11788568/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Kidney Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ckj/sfae402\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Kidney Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ckj/sfae402","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景:深度低钠血症的最佳治疗方法仍不确定。最近的临床研究表明,标准剂量的高渗生理盐水是有效的,但仅仅依靠这种方法可能无法完全解决患者低钠血症的个体差异。我们评估了快速给药(RB)高渗生理盐水,然后使用与基于Edelman方程(RB-PC)的Barsoum-Levine公式相同的输液和液体损失公式预测校正(PC)治疗深度低钠血症的有效性。方法:在这项回顾性观察队列研究中,我们评估了276例年龄在bb0 - 18岁,s[Na]水平≤120meq /L(2014年1月- 2023年12月)的患者。使用倾向评分匹配(PSM),我们评估了RB-PC组和PC组在治疗开始后6小时的s[Na]升高和适当的低钠血症纠正率。我们将适当的校正定义为校正治疗开始后的前24小时内s[Na]变化在4-10 mEq/L范围内,并且在前48小时内≤18 mEq/L。结果:276例深度低钠血症(s[Na]≤120meq /L)患者中,49例采用RB-PC治疗,108例采用PC治疗,不采用RB治疗。psm后,84例患者被分为RB-PC组(n = 42)和PC组(n = 42)。在PSM分析中,RB-PC患者在治疗开始后6 h的s[Na]升高高于PC (4.0 vs 2.4 mEq/L, P P = 1)。结论:RB-PC可快速升高深度低钠血症患者的s[Na]水平并实现适当的s[Na]纠正。
Correction of profound hyponatraemia following rapid bolus therapy: effectiveness of the Barsoum-Levine formula based on the Edelman equation.
Background: The optimal treatment for profound hyponatraemia remains uncertain. Recent clinical studies have demonstrated that a standardized bolus of hypertonic saline is effective, but relying solely on this approach may not fully address the individual variability of hyponatraemia among patients. We evaluated the effectiveness of rapid bolus (RB) administration of hypertonic saline followed by predictive correction (PC) using an infusate and fluid loss formula identical to the Barsoum-Levine formula based on the Edelman equation (RB-PC) for managing profound hyponatraemia.
Methods: In this retrospective observational cohort study, we evaluated 276 patients aged >18 years with s[Na] levels ≤120 mEq/L (January 2014-December 2023). Using propensity score matching (PSM), we assessed s[Na] elevations at 6 h post-treatment initiation and the rate of appropriate hyponatraemia correction between the RB-PC and PC groups. We defined the appropriate correction as a change in s[Na] in the range of 4-10 mEq/L within the first 24 h and ≤18 mEq/L within the first 48 h following corrective treatment initiation.
Results: Among 276 patients with profound hyponatraemia (s[Na] ≤120 mEq/L), 49 and 108 underwent treatment with RB-PC therapy and with PC therapy without RB, respectively. Post-PSM, 84 patients were selected and allocated to the RB-PC (n = 42) or PC group (n = 42). In PSM analysis, patients with RB-PC experienced a higher elevation in s[Na] at 6 h after treatment initiation than PC (4.0 vs 2.4 mEq/L, P < 0.001). The rate of appropriate correction was similar between the RB-PC and PC groups (90.5% vs 90.5%, P = 1).
Conclusions: RB-PC can quickly elevate s[Na] levels and achieve appropriate correction of s[Na] in patients with profound hyponatraemia.
期刊介绍:
About the Journal
Clinical Kidney Journal: Clinical and Translational Nephrology (ckj), an official journal of the ERA-EDTA (European Renal Association-European Dialysis and Transplant Association), is a fully open access, online only journal publishing bimonthly. The journal is an essential educational and training resource integrating clinical, translational and educational research into clinical practice. ckj aims to contribute to a translational research culture among nephrologists and kidney pathologists that helps close the gap between basic researchers and practicing clinicians and promote sorely needed innovation in the Nephrology field. All research articles in this journal have undergone peer review.